Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2010-02-28
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The first phase involved creation of a Spanish adaptation of the Melodic Intonation therapy; the second phase consisted of a pilot non-randomized intervention study to analyse its feasibility for use with 4 Spanish patients with poststroke nonfluent aphasia; the third phase consisted of a pilot randomised, crossover, intervention pilot trial in a different set of patients with poststroke nonfluent aphasia (N=20)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
New Therapeutical Perspectives in Cases of Phonological Disorders
NCT02935062
Memorisation of Phonologic Information Among Children With Oral Language Developement Disorder
NCT02609542
Validating Neuropsych Tests in Spanish-speakers
NCT05185635
Stuttering and Apraxia of Speech: the Efficacy of an Intervention Program
NCT01097161
Melodic Intonation Therapy for Tone Language Speakers
NCT04221386
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Melodic Intonation Therapy
The duration of therapy was 12 sessions performed over a 6-week period. Each session lasted 30 minutes. They were performed individually by a speech-experienced therapist previously trained in Melodic Intonation Therapy.
Melodic Intonation Therapy
Waiting list
No intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Melodic Intonation Therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The time elapsed since the stroke exceeded 6 months.
* Patient had received a standard program of conventional speech therapy after stroke.
* Persistent nonfluent aphasia with the following characteristics:
* Severely restricted language, which might be limited to meaningless stereotypy; unlike that observed in verbal tasks, the patient might produce some real and relevant words when singing familiar songs.
* Poor repetition, even for single words.
* Moderately preserved language comprehension.
* The nonstereotyped language was produced with a slurring of speech.
* The total score for the repetition did not exceed the 70th percentile in the Boston Diagnostic Aphasia Examination. The score was obtained from the average score in three areas: repetition of words and repetition of phrases; listening comprehension exceeding the 15th percentile of Boston Diagnostic Aphasia Examination; and from the average score obtained in three areas: word comprehension, commands and complex ideational material.
* The patient was motivated, emotionally stable and had good attention.
* Signed informed consent was provided.
Exclusion Criteria
* patients participating in any therapeutic intervention clinical trials evaluating poststroke recovery
* use of psychotropic drugs that interfere with patient evaluation.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto de Investigación Hospital Universitario La Paz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI-894
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.